1,000
Participants
Start Date
April 9, 2020
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2027
Data collection
In particular, the patient's demographic data, medical history, previous and concomitant treatments, data on the treatment of interest (legal framework, compassionate use/ off-label), dosage, start date, etc.), clinical data will be collected. biological (including molecular profiling of the tumor if available) and radiological follow-up, information on adverse effects. The data to be filled in is that of the CERFA pharmacovigilance form of the ANSM, but additional fields can be created if necessary.
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
CHU Amiens, Amiens
RECRUITING
CHU Angers, Angers
RECRUITING
CHU Besançon, Besançon
RECRUITING
CHU Bordeaux, Bordeaux
RECRUITING
CHU CAEN, Caen
RECRUITING
CHU Clermont-Ferrand, Clermont-Ferrand
RECRUITING
CHU Dijon, Dijon
RECRUITING
CHU Grenoble, Grenoble
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
CHU Lille, Lille
RECRUITING
CHU Limoges, Limoges
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
CHU Lyon, Lyon
RECRUITING
Hôpital de La Timone, Marseille
RECRUITING
CHU Montpellier, Montpellier
RECRUITING
CHU Nancy, Nancy
RECRUITING
CHU Nantes, Nantes
RECRUITING
CHU Nice, Nice
RECRUITING
Hôpital Armand Trousseau, Paris
RECRUITING
Hôpital Robert-Debré, Paris
RECRUITING
Institut Curie, Paris
RECRUITING
CHU Poitiers, Poitiers
RECRUITING
CHU Reims, Reims
RECRUITING
CHU Rennes, Rennes
RECRUITING
CHU Rouen, Rouen
RECRUITING
CHU La Réunion, Saint-Denis
RECRUITING
CHU Saint-Etienne, Saint-Etienne
RECRUITING
CHU Strasbourg, Strasbourg
RECRUITING
CHU Toulouse, Toulouse
RECRUITING
CHU Tours, Tours
Gustave Roussy, Cancer Campus, Grand Paris
OTHER